Bethany Sensenig
Förmögenhet: 47 974 $ per 2026-10-31
Förmögenhet: 47 974 $ per 2026-10-31
Bethany L.
Sensenig currently serves as Independent Director at Supernus Pharmaceuticals, Inc. since 2023, Independent Director at Alpha Cognition, Inc. starting 2026, Independent Director at Supernus, Inc. starting 2026, Chief Executive & Financial Officer at Naia Rare Diseases LLC, and Chief Financial Officer at CenExel Clinical Research, Inc. Former roles include Independent Director at KalVista Pharmaceuticals, Inc. from 2025 to 2026, Vice President-Finance & Commercial Operations at Biogen, Inc. from 2006 to 2019, Chief Financial Officer & Head-Operations at Radius Health, Inc. from 2023 to 2026, Chief Executive & Financial Officer at 9 Meters Biopharma, Inc. in 2023, and Chief Financial Officer & Head-US Operations at Minovia Therapeutics Ltd. from 2019 to 2022.
Education includes undergraduate studies at Montreat College and an MBA from Western Carolina University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ALPHA COGNITION INC 0,03 % | 2026-04-16 | 5 489 ( 0,03 % ) | 47 974 $ | 2026-10-31 |
-.--% | 2026-11-02 | 0 ( -.--% ) | - $ | 2026-10-31 |
| Företag | Position | Start |
|---|---|---|
| SUPERNUS PHARMACEUTICALS | Direktör/Styrelseledamot | 2023-08-21 |
| ALPHA COGNITION INC. | Direktör/Styrelseledamot | 2026-04-15 |
Naia Rare Diseases LLC
Naia Rare Diseases LLC Medical/Nursing ServicesHealth Services Manufactures biopharmaceutical products | Verkställande Direktör | - |
CenExel Clinical Research, Inc.
CenExel Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research, medical and scientific support services for clinical trials | Finansdirektör/CFO | - |
| Företag | Position | Slut |
|---|---|---|
| KALVISTA PHARMA | Direktör/Styrelseledamot | 2026-06-11 |
| RADIUS HEALTH, INC. | Finansdirektör/CFO | 2026-04-01 |
| 9 METERS BIOPHARMA, INC. | Verkställande Direktör | 2023-07-17 |
Minovia Therapeutics Ltd.
Minovia Therapeutics Ltd. BiotechnologyHealth Technology Develops mitochondrial cell therapies for clinical-stage biotechnology company | Finansdirektör/CFO | 2022-01-01 |
| BIOGEN INC. | Företagsledare/Principal | 2019-03-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 11 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Montreat College
Montreat College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Western Carolina University
Western Carolina University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of central nervous system diseases | Health Technology |
KalVista Pharmaceuticals, Inc.
KalVista Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets small molecule protease inhibitors for diseases | Health Technology |
9 Meters Biopharma, Inc.
9 Meters Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for people with rare digestive diseases and gastrointestinal conditions | Health Technology |
CenExel Clinical Research, Inc.
CenExel Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research, medical and scientific support services for clinical trials | Commercial Services |
Minovia Therapeutics Ltd.
Minovia Therapeutics Ltd. BiotechnologyHealth Technology Develops mitochondrial cell therapies for clinical-stage biotechnology company | Health Technology |
Naia Rare Diseases LLC
Naia Rare Diseases LLC Medical/Nursing ServicesHealth Services Manufactures biopharmaceutical products | Health Services |
Alpha Cognition, Inc.
Alpha Cognition, Inc. Financial ConglomeratesFinance Develops pharmaceutical products for treating neurodegenerative diseases | Finance |
Välj din utgåva
All finansiell information anpassad till den nationella nivån